Beatriz Silva Lima PhD

Beatriz joined the NDA Advisory Board in 2013. She is an expert in non-clinical safety strategies for chemical, biological & advanced therapies. Her strategic & scientific expertise is essential for the successful development of new medicinal products, emerging technologies, and the regulatory expectations set by the Agencies.